Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Anna Bawden Health and social affairs correspondent

Hundreds of weight loss and diabetes jab users report pancreas problems

A box, jab and instruction leflet for Mounjaro
Nearly half of the reports received to date involved tirzepatide, sold under the brand name Mounjaro. Photograph: MK Photo/Alamy

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to launch a study into side-effects.

Some cases of pancreatitis reported to be linked to GLP-1 medicines (glucagon-like peptide-1 receptor agonists) have been fatal.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.